CA3077088A1 - Process for preparing spiro derivatives - Google Patents

Process for preparing spiro derivatives Download PDF

Info

Publication number
CA3077088A1
CA3077088A1 CA3077088A CA3077088A CA3077088A1 CA 3077088 A1 CA3077088 A1 CA 3077088A1 CA 3077088 A CA3077088 A CA 3077088A CA 3077088 A CA3077088 A CA 3077088A CA 3077088 A1 CA3077088 A1 CA 3077088A1
Authority
CA
Canada
Prior art keywords
compound
preparing
followed
methyl
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CA3077088A
Other languages
English (en)
French (fr)
Inventor
Gerard M. P. Giblin
David T. Macpherson
Osama SULEIMAN
Michael Williams
David R. Witty
Thierry Bonnaud
Richard Edwards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of CA3077088A1 publication Critical patent/CA3077088A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C07C65/10—Salicylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Measuring Volume Flow (AREA)
  • Exhaust Gas After Treatment (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA3077088A 2017-10-10 2018-10-10 Process for preparing spiro derivatives Withdrawn CA3077088A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762570269P 2017-10-10 2017-10-10
US62/570,269 2017-10-10
PCT/US2018/055227 WO2019075073A2 (en) 2017-10-10 2018-10-10 PROCESS FOR THE PREPARATION OF SPIRO DERIVATIVES

Publications (1)

Publication Number Publication Date
CA3077088A1 true CA3077088A1 (en) 2019-04-18

Family

ID=66100090

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3077088A Withdrawn CA3077088A1 (en) 2017-10-10 2018-10-10 Process for preparing spiro derivatives

Country Status (12)

Country Link
US (2) US11149039B2 (OSRAM)
EP (1) EP3694510A4 (OSRAM)
JP (1) JP2020536898A (OSRAM)
KR (1) KR20200068678A (OSRAM)
CN (1) CN111526874A (OSRAM)
AU (1) AU2018347349A1 (OSRAM)
CA (1) CA3077088A1 (OSRAM)
IL (1) IL273695A (OSRAM)
MA (1) MA50371A (OSRAM)
MX (2) MX2020003821A (OSRAM)
SG (1) SG11202002707VA (OSRAM)
WO (1) WO2019075073A2 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018347349A1 (en) 2017-10-10 2020-04-23 Biogen Inc. Process for preparing spiro derivatives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US814396A (en) 1905-05-22 1906-03-06 Joseph R Russell Burner for liquid fuel.
KR0178475B1 (ko) 1995-09-14 1999-03-20 윤덕용 신규한 n-비닐락탐 유도체 및 그의 중합체
EP1519939B9 (en) 2002-07-05 2011-04-06 Targacept, Inc. N-aryl diazaspirocyclic compounds and methods of preparation and use thereof
US7501528B2 (en) 2005-03-15 2009-03-10 Hoffmann-La Roche Inc. Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives
US8143306B2 (en) 2005-10-10 2012-03-27 Convergence Pharmaceuticals Limited Methods of treating bipolar disorders
TW200728258A (en) 2005-10-10 2007-08-01 Glaxo Group Ltd Novel compounds
DE602006015215D1 (de) 2005-10-10 2010-08-12 Glaxo Group Ltd Prolinamidderivate als natriumkanalmodulatoren
GB0520578D0 (en) 2005-10-10 2005-11-16 Glaxo Group Ltd Novel compounds
TW200730494A (en) 2005-10-10 2007-08-16 Glaxo Group Ltd Novel compounds
AR063278A1 (es) 2006-10-12 2009-01-14 Xenon Pharmaceuticals Inc Compuestos de espiro-oxindol, una composicion farmaceutica que los comprende y su uso para el tratamiento de enfermedades o condiciones mediadas por los canales de sodio.
AU2007307635A1 (en) 2006-10-12 2008-04-17 Xenon Pharmaceuticals Inc. Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents
WO2008090114A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
GB0701366D0 (en) 2007-01-24 2007-03-07 Glaxo Group Ltd Novel pharmaceutical compositions
GB0701365D0 (en) 2007-01-24 2007-03-07 Glaxo Group Ltd Novel pharmaceutical compositions
GB0706630D0 (en) 2007-04-04 2007-05-16 Glaxo Group Ltd Novel compounds
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
HRP20150491T1 (hr) 2009-09-14 2015-08-14 Convergence Pharmaceuticals Limited PROCES PRIPREME DERIVATA α-KARBOKSAMIDA
US8618303B2 (en) 2011-01-07 2013-12-31 Hoffmann-La Roche Inc. Pyrrolidine derivatives
BR112013026116A2 (pt) * 2011-04-26 2016-12-27 Hoffmann La Roche derivados etinílicos como moduladores alostéricos positivos de mglur5
GB201122113D0 (en) * 2011-12-22 2012-02-01 Convergence Pharmaceuticals Novel compounds
GB201209015D0 (en) 2012-05-22 2012-07-04 Convergence Pharmaceuticals Novel compounds
GB201209670D0 (en) 2012-05-31 2012-07-18 Convergence Pharmaceuticals Novel compounds
KR102485537B1 (ko) 2014-08-04 2023-01-05 메르크 파텐트 게엠베하 Metap-2 저해제로서의 피롤리디논 유도체
MA50669A (fr) 2017-09-28 2020-08-05 Biogen Inc Nouveaux sels
AU2018347349A1 (en) 2017-10-10 2020-04-23 Biogen Inc. Process for preparing spiro derivatives

Also Published As

Publication number Publication date
EP3694510A4 (en) 2021-06-30
MA50371A (fr) 2021-03-31
IL273695A (en) 2020-05-31
JP2020536898A (ja) 2020-12-17
WO2019075073A3 (en) 2020-04-02
US20200325144A1 (en) 2020-10-15
KR20200068678A (ko) 2020-06-15
MX2020003821A (es) 2023-01-12
SG11202002707VA (en) 2020-04-29
CN111526874A (zh) 2020-08-11
US11149039B2 (en) 2021-10-19
WO2019075073A2 (en) 2019-04-18
US20220033408A1 (en) 2022-02-03
MX2022013928A (es) 2022-11-30
AU2018347349A1 (en) 2020-04-23
EP3694510A2 (en) 2020-08-19

Similar Documents

Publication Publication Date Title
Teller et al. Concise synthesis of the antidepressive drug candidate GSK1360707 by a highly enantioselective gold-catalyzed enyne cycloisomerization reaction
JP5279789B2 (ja) キラルプロピオン酸誘導体の製造方法
JP2009532345A (ja) テトラヒドロキノリン誘導体の製造方法
JP6800334B2 (ja) Ｂｔｋ阻害剤を調製するプロセス
US8222452B2 (en) Method for producing optically active amines
CN109890790B (zh) 一种奥司他韦及其异构体的制备方法
JP2015518821A (ja) リシン−グルタミン酸ジペプチド誘導体
KR101368501B1 (ko) 프로피온산 유도체의 제조 방법
JP2023534965A (ja) Ｃ－ヌクレオシド化合物の合成方法
CN113717176B (zh) 一种制备瑞马唑仑的方法
CN108503610B (zh) 一种光学纯的(r)-4-正丙基-二氢呋喃-2(3h)-酮的制备方法
CN114096529A (zh) 化学方法
JP2021193127A (ja) （５ｓ，１０ｓ）−１０−ベンジル−１６−メチル−１１，１４，１８−トリオキソ−１５，１７，１９−トリオキサ−２，７，８−トリチア−１２−アザヘンイコサン−５−アミニウム（ｅ）−３−カルボキシアクリレート塩の調製のための工業的プロセス
CA3077088A1 (en) Process for preparing spiro derivatives
CN104193643B (zh) 用于合成抗艾滋病药物增强剂cobicistat的中间体
CN109456253B (zh) 一种手性诱导合成(s)-3-(4-溴苯基)-哌啶或其盐的方法
CA2692919A1 (en) Process for the production of tertiary alcohols
CN113121549B (zh) 立体选择性合成手性内酯的方法和手性化合物及其应用
HK40035061A (en) Process for preparing spiro derivatives
CN108276402A (zh) 一种盐酸莫西沙星的制备方法
JP4691230B2 (ja) 光学活性１−（ベンゾフラン−２−イル）−２−プロピルアミノペンタンの製造方法
WO2020213714A1 (ja) シス－（－）－フロシノピペリドールの製造方法
JP2020502148A (ja) ジアゼピン誘導体の製造のための方法
CN106588841B (zh) 合成2,3-二氢-1-苯并呋喃-4-甲醛的方法
CN119798218A (zh) 一种e3酶配体-连接链复合物及其制备方法

Legal Events

Date Code Title Description
AZWI Withdrawn application

Effective date: 20230824